RxDoctor Payments Data

Kadra Vaccaro

Physician Assistant · Sacramento, CANPI 1356112262

Payments from drug & device makers

$4,000in general payments, 2019–2025

Across 164 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$455
  • Pfizer$416
  • AstraZeneca$389
  • AbbVie$373
  • Lilly USA, LLC$294
  • Bayer$280
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$3,991100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,000 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol16$19,984
OzempicSemaglutide16$14,732
Breo ElliptaFluticasone/Vilanterol11$3,741
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$3,546
Omega-3 Acid Ethyl Esters24$2,626
Lidocaine35$2,433
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen72$1,820
Pregabalin22$1,695
Albuterol Sulfate HfaAlbuterol Sulfate62$1,552
Atorvastatin Calcium143$1,012
Gabapentin69$951
Ondansetron OdtOndansetron21$886
Fluoxetine Hcl14$869
Duloxetine Hcl26$641
Sumatriptan Succinate12$538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$389$19,98416 claims
Novo NordiskOzempic$455$14,73216 claims
GSKBreo Ellipta$187$3,74111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →